Risk assessment of latent tuberculosis infection through a multiplexed cytokine biosensor assay and machine learning feature selection
Authors:
Open Access
- 15 October 2021
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 11 (1) , 1-10
Abstract
Accurate detection and risk stratification of latent tuberculosis infection (LTBI) remains a major clinical and public health problem. We hypothesize that multiparameter strategies that probe immune responses to Mycobacterium tuberculosis can provide new diagnostic insights into not only the status of LTBI infection, but also the risk of reactivation. After the initial proof-of-concept study, we developed a 13-plex immunoassay panel to profile cytokine release from peripheral blood mononuclear cells stimulated separately with Mtb-relevant and non-specific antigens to identify putative biomarker signatures. We sequentially enrolled 65 subjects with various risk of TB exposure, including 32 subjects with diagnosis of LTBI. Random Forest feature selection and statistical data reduction methods were applied to determine cytokine levels across different normalized stimulation conditions. Receiver Operator Characteristic (ROC) analysis for full and reduced feature sets revealed differences in biomarkers signatures for LTBI status and reactivation risk designations. The reduced set for increased risk included IP-10, IL-2, IFN-γ, TNF-α, IL-15, IL-17, CCL3, and CCL8 under varying normalized stimulation conditions. ROC curves determined predictive accuracies of > 80% for both LTBI diagnosis and increased risk designations. Our study findings suggest that a multiparameter diagnostic approach to detect normalized cytokine biomarker signatures might improve risk stratification in LTBI.Keywords
Funding Information
- National Institute of Allergy and Infectious Diseases at the National Institutes of Health (AI141591, AI141591)
- National Center for Advancing Translational Sciences (UL1 TR000135)
This publication has 36 references indexed in Scilit:
- CCL2, CCL3 and CCL4 gene polymorphisms in pulmonary tuberculosis patients of South IndiaInternational Journal of Immunogenetics, 2013
- Predictive value of interferon-γ release assays for incident active tuberculosis: a systematic review and meta-analysisThe Lancet Infectious Diseases, 2012
- Multiple Cytokines Are Released When Blood from Patients with Tuberculosis Is Stimulated with Mycobacterium tuberculosis AntigensPLOS ONE, 2011
- Essential Role of IL-17A in the Formation of a Mycobacterial Infection-Induced Granuloma in the LungThe Journal of Immunology, 2010
- CCL2 Responses to Mycobacterium tuberculosis Are Associated with Disease Severity in TuberculosisPLOS ONE, 2009
- Host markers in Quantiferon supernatants differentiate active TB from latent TB infection: preliminary reportBMC Pulmonary Medicine, 2009
- LTBI: latent tuberculosis infection or lasting immune responses toM. tuberculosis? A TBNET consensus statementEuropean Respiratory Journal, 2009
- IP-10, MCP-1, MCP-2, MCP-3, and IL-1RA hold promise as biomarkers for infection with M. tuberculosis in a whole blood based T-cell assayBMC Research Notes, 2009
- IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challengeNature Immunology, 2007
- Epidemiologic Differences between United States– and Foreign‐Born Tuberculosis Patients in Houston, TexasThe Journal of Infectious Diseases, 2001